Trial Profile
A retrospective, open-label, observational study evaluating the efficacy, safety, and tolerability of lacosamide as add-on therapy in patients with Lennox–Gastaut syndrome
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2016
Price :
$35
*
At a glance
- Drugs Lacosamide (Primary)
- Indications Lennox-Gastaut syndrome
- Focus Adverse reactions; Therapeutic Use
- 06 Nov 2016 New trial record